Summary:
-
Canadian Trial Approval
Neuralink has received approval to launch its first clinical trial in Canada, testing its brain chip to help paralyzed individuals control devices with their thoughts. -
Focus of the Study
The trial aims to evaluate the safety and functionality of the implant for individuals with quadriplegia, enabling them to interact with digital devices. -
Advanced Surgical Collaboration
The procedure will be performed at Toronto’s University Health Network, a facility specializing in complex neurosurgical operations. -
Previous Success in the US
Two patients in the US have already received the implants, with one using it to play video games and design 3D objects. -
Potential Impact
This trial marks a significant step in assistive technology, offering hope for enhanced digital accessibility for people with severe mobility challenges.
Read more at: Reuters